Narrow search
Showing 1 - 10 of 18
Cover Image
The objectives of the FDA's Office of generic drugs
Scott Morton, Fiona - 1997
Persistent link: https://www.econbiz.de/10000638173
Cover Image
Entry decisions in the generic pharmaceutical industry
Scott Morton, Fiona - 1997
Persistent link: https://www.econbiz.de/10000640894
Cover Image
Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry
Scott Morton, Fiona - In: International journal of industrial organization 18 (2000) 7, pp. 1085-1104
Persistent link: https://www.econbiz.de/10001498868
Cover Image
Entry decisions in the generic pharmaceutical industry
Scott Morton, Fiona - In: The Rand journal of economics 30 (1999) 3, pp. 421-440
Persistent link: https://www.econbiz.de/10001431734
Cover Image
Horizontal integration between brand and generic firms in the pharmaceutical industry
Scott Morton, Fiona - In: Journal of economics & management strategy : JEMS 11 (2002) 1, pp. 135-168
Persistent link: https://www.econbiz.de/10001650143
Cover Image
The strategic response by pharmaceutical firms to the medicaid most-favored-customer rules
Scott Morton, Fiona - 1996
Persistent link: https://www.econbiz.de/10000601917
Cover Image
Market size and pharmaceutical innovation
Dubois, Pierre; Mouzon, Olivier de; Scott Morton, Fiona; … - 2011
Persistent link: https://www.econbiz.de/10009378418
Cover Image
The strategic response by pharmaceutical firms to the Medicaid most-favored-customer rules
Scott Morton, Fiona - In: The Rand journal of economics 28 (1997) 2, pp. 269-290
Persistent link: https://www.econbiz.de/10001224186
Cover Image
Market size and pharmaceutical innovation
Dubois, Pierre; Mouzon, Oliver de; Scott Morton, Fiona; … - 2011
Persistent link: https://www.econbiz.de/10009012141
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - In: Review of industrial organization : RIO 53 (2018) 1, pp. 173-210
Persistent link: https://www.econbiz.de/10012009103